Detalhe da pesquisa
1.
[HBeAg seroconversion achieved by sequential peginterferon alfa-2a therapy in chronic hepatitis B patients with unsatisfactory end point following entecavir treatment].
Zhonghua Gan Zang Bing Za Zhi
; 21(7): 502-5, 2013 Jul.
Artigo
em Zh
| MEDLINE | ID: mdl-24074707
2.
[Individualized respond guidance treatment of chronic hepatitis C with combination of peginterferon α-2a and ribavirin].
Zhonghua Gan Zang Bing Za Zhi
; 18(8): 585-9, 2010 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-20825712
3.
Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment.
Drug Des Devel Ther
; 13: 3569-3578, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31802845
4.
Application of organic polymeric flocculants in centrifugal dewatering of oil refinery sludge.
J Environ Sci (China)
; 15(4): 510-3, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12974313
5.
[Hydroxyapatite nanoparticles enhance the efficacy of liposome-mediated gene-transfection into HepG2 cells and its mechanisms].
Zhonghua Zhong Liu Za Zhi
; 30(2): 111-2, 2008 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-18646692
6.
[Prevalence and clinical characteristics of thyroid disease induced by chronic hepatitis B treated with polyethylene glycol (peg) interferon-alpha].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
; 26(2): 117-9, 2012 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-23002550
7.
Oval cell response is attenuated by depletion of liver resident macrophages in the 2-AAF/partial hepatectomy rat.
PLoS One
; 7(4): e35180, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22514719